Vicapsys Life Sciences, Inc. (VICP)

USD 1.77

(39.37%)

Long Term Debt Summary of Vicapsys Life Sciences, Inc.

  • Vicapsys Life Sciences, Inc.'s latest annual long term debt in 2023 was - USD , down 0.0% from previous year.
  • Vicapsys Life Sciences, Inc.'s latest quarterly long term debt in 2023 Q1 was - USD , down 0.0% from previous quarter.
  • Vicapsys Life Sciences, Inc. reported annual long term debt of - USD in 2022, down 0.0% from previous year.
  • Vicapsys Life Sciences, Inc. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • Vicapsys Life Sciences, Inc. reported quarterly long term debt of - USD for 2023 Q2, down 0.0% from previous quarter.
  • Vicapsys Life Sciences, Inc. reported quarterly long term debt of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Vicapsys Life Sciences, Inc. (2023 - 2008)

Historical Annual Long Term Debt of Vicapsys Life Sciences, Inc. (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2009 1.31 Million USD 218.19%
2008 414.41 Thousand USD 0.0%

Peer Long Term Debt Comparison of Vicapsys Life Sciences, Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Aridis Pharmaceuticals, Inc. 1.29 Million USD 100.0%
Biora Therapeutics, Inc. 43.73 Million USD 100.0%
Bio-Path Holdings, Inc. 10 Thousand USD 100.0%
Better Therapeutics, Inc. 10.34 Million USD 100.0%
Calithera Biosciences, Inc. 136 Thousand USD 100.0%
Comera Life Sciences Holdings, Inc. 120.3 Thousand USD 100.0%
Gene Biotherapeutics, Inc. - USD NaN%
eFFECTOR Therapeutics, Inc. - USD NaN%
Eloxx Pharmaceuticals, Inc. 8.69 Million USD 100.0%
Evelo Biosciences, Inc. 48.87 Million USD 100.0%
Evolutionary Genomics, Inc. 3.74 Million USD 100.0%
Finch Therapeutics Group, Inc. 28.4 Million USD 100.0%
Galera Therapeutics, Inc. 151.04 Million USD 100.0%
Innovation1 Biotech Inc. 218.99 Thousand USD 100.0%
Kiromic BioPharma, Inc. 911.5 Thousand USD 100.0%
Molecular Templates, Inc. 9.74 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 100.0%
NexImmune, Inc. - USD NaN%
Orgenesis Inc. 19.06 Million USD 100.0%
Panbela Therapeutics, Inc. 4.19 Million USD 100.0%
Point of Care Nano-Technology, Inc. - USD NaN%
PaxMedica, Inc. Common Stock - USD NaN%
Scopus BioPharma Inc. - USD NaN%
Sorrento Therapeutics, Inc. 104.33 Million USD 100.0%
Statera Biopharma, Inc. 11.43 Million USD 100.0%
TRACON Pharmaceuticals, Inc. 732 Thousand USD 100.0%
Trevena, Inc. 35.23 Million USD 100.0%
Vaxxinity, Inc. 13.26 Million USD 100.0%
Vaccinex, Inc. 26 Thousand USD 100.0%
Viracta Therapeutics, Inc. - USD NaN%
ZIVO Bioscience, Inc. - USD NaN%